Infertility Clinical Trial
Official title:
A Randomized, Three-armed, Non-Inferiority Study of Vaginal Progesterone (Endometrin®) Compared to Intramuscular Progesterone in Oil (PIO) in Infertile Subjects Undergoing Frozen Embryo Transfer (FET)
To determine whether the of vaginal progesterone replacement for frozen embryo transfer results in equivalent live birth rates to intramuscular injection progesterone replacement.
The purpose of this ongoing study is to look at whether Endometrin® (vaginal micronized
progesterone tablets) supplemented by intramuscular injection of progesterone in oil (PIO)
work as well as PIO alone for women undergoing transfer of frozen-thawed blastocyst(s).
Another goal of the study is to determine whether patients prefer Endometrin or PIO.
Endometrin® has been approved by the United States Food and Drug Administration, or FDA, "to
support embryo implantation and early pregnancy by supplementation of corpus luteal function
as part of an Assisted Reproductive Technology (ART) treatment program for infertile women."
(FDA New Drug Approval Letter, Endometrin®, 2007). The use of Endometrin® (vaginal micronized
progesterone tablets) in this study is investigational. An investigational use is one that is
not approved by the U.S. Food and Drug Administration (FDA).
Approximately 1170 women between the ages of 18-48 who are having difficulty becoming
pregnant and wish to undergo frozen embryo transfer will be asked to participate. The
participants will be recruited from among patients of Shady Grove Fertility.
One-half of the participants who qualify and wish to take part in the ongoing study will be
randomized (assigned by chance, like the flip of a coin) to receive Endometrin® and an
intramuscular injection of PIO every third day. One-half will be randomized to receive an
intramuscular injection of PIO every day. This study is a type of study called an "open
label," assessor-blind study. This means that you and your doctor will know which treatment
you are assigned and receive; however, the person analyzing the information obtained from the
study will not know which patients received which study treatments.
Patients enrolling in the study will receive the medications for their frozen embryo transfer
cycle free of charge.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A |